IL6 and neuroblastoma: The studies by Lagmay et al. [15] have shown that the single nucleotide polymorphism (SNP) rs1800795 in IL-6 promoter (−174 G>C) is associated with unfavorable clinical outcome in patients affected by high-risk NB.